Expertise in
8
conditions

Graham P. Leese

Dundee, SCT, GB 
Expertise in
8
conditions
Dundee, SCT, GB 
OverviewLocationsClinical Research

Overview

Graham Leese practices in Dundee, United Kingdom. Mr. Leese is highly rated in 8 conditions, according to our data. His top areas of expertise are Hypothyroidism, Hyperparathyroidism, Type 2 Diabetes (T2D), Hormone Replacement Therapy (HRT), and Parathyroidectomy.

His clinical research consists of co-authoring 120 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

Dundee, SCT DD14HN, United Kingdom
Other Locations
St Bartholomew's Hospital, Barts Health NHS Trust
London, ENG, United Kingdom
NHS Fife
Kirkcaldy, SCT, United Kingdom
Ninewells Hopsital, Dundee DD1 9SY, Mackenzie Building, Kirsty Semple Way, Dundee DD2 4BF, Inverness IV2 3UJ, Scottish Renal Registry, Cirrus House, Marchburn Drive, Glasgow Airport Business Park, Abbotsinch Paisley PA3 2SJ, 47 Little France Crescent, Edinburgh EH16 4TJ, Dundee DD1 9SY, Aberdeen AB25 1LD, Teviot Place, Edinburgh EH8 9AG, 126 University Place, Glasgow G12 8TA, Crewe Road South, Edinburgh EH4 2XU And NHS Grampian, Aberdeen Royal Infirmary, Eday Road, Aberdeen, SCT AB156XS, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Randomized, Double-blind, Placebo-controlled, Adaptive Study to Evaluate Symptom Improvement and Metabolic Control Among Adult Subjects With Symptomatic Hypoparathyroidism Treated With Recombinant Human Parathyroid Hormone [rhPTH(1-84)]
A Randomized, Double-blind, Placebo-controlled, Adaptive Study to Evaluate Symptom Improvement and Metabolic Control Among Adult Subjects With Symptomatic Hypoparathyroidism Treated With Recombinant Human Parathyroid Hormone [rhPTH(1-84)]
Enrollment Status: Completed
Publish Date: June 09, 2023
Intervention Type: Biological
Study Drug: rhPTH(1-84)
Study Phase: Phase 4

120 Total Publications

rhPTH(1-84) for hypoparathyroidism: a randomized study of patient-reported outcomes.
rhPTH(1-84) for hypoparathyroidism: a randomized study of patient-reported outcomes.
Journal: European journal of endocrinology
Published: May 12, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Leese's expertise for a condition
ConditionClose
    View All 13 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile